SELLAS Life Sciences Group, Inc. Dividends Payable
SELLAS Life Sciences Group, Inc. (SLS) had Dividends Payable of $375.00 thousand as of 2018-06-30, per its 10-Q filed 2018-08-14.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities
us-gaap:DividendsPayableCurrentAndNoncurrent · last filed 2018-08-14
- 2018-06-30: Dividends Payable $375.00K.
- 2017-12-31: Dividends Payable $0.00.
| Period end | Dividends Payable |
|---|---|
| 2018-06-30 | $375.00K 10-Q · filed 2018-08-14 |
| 2017-12-31 | $0.00 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |